Atopic dermatitis in African American children: Addressing unmet needs of a common disease

Pediatric Dermatology

Volumn 29, Issue 4, 2012, Pages 395-402

  Vachiramon, Vasanop ^a,b   Tey, Hong Liang ^a,c   Thompson, Amy E ^a   Yosipovitch, Gil ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c NATIONAL SKIN CENTRE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

AFRICAN AMERICAN; ALOPECIA; ATOPIC DERMATITIS; CAUCASIAN; CHILDHOOD DISEASE; CORTICOSTEROID THERAPY; DERMATOLOGIST; DISEASE SEVERITY; DRUG SAFETY; HUMAN; IMMUNE SYSTEM; LIVER TOXICITY; MEDLINE; MORPHOLOGY; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT MONITORING; PHOTOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PRURITUS; RACE DIFFERENCE; REVIEW; SKIN COLOR; STAPHYLOCOCCUS AUREUS; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

AFRICAN AMERICANS; CHILD; DERMATITIS, ATOPIC; HUMANS; NEEDS ASSESSMENT; PREVALENCE; UNITED STATES;

EID: 84863486224     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2012.01740.x     Document Type: Review

References (56)

1. Shaw TE, Currie GP, Koudelka CW, et al., Eczema prevalence in the United States: data from the 2003 National Survey of Children's Health. J Invest Dermatol 2011; 131: 67-73.
2. Elias PM, Hatano Y, Williams ML,. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008; 121: 1337-1343.
3. Jungersted JM, Hogh JK, Hellgren LI, et al., Ethnicity and stratum corneum ceramides. Br J Dermatol 2010; 163: 1169-1173.
4. Proksch E, Folster-Holst R, Brautigam M, et al., Role of the epidermal barrier in atopic dermatitis. J Dtsch Dermatol Ges 2009; 7: 899-910.
5. Wesley NO, Maibach HI,. Racial (ethnic) differences in skin properties: the objective data. Am J Clin Dermatol 2003; 4: 843-860. (Pubitemid 38030860)
6. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al., Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-446.
7. Rodriguez E, Baurecht H, Herberich E, et al., Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol 2009; 123: 1361-1370.
8. Eberlein-Konig B, Schafer T, Huss-Marp J, et al., Skin surface pH, stratum corneum hydration, trans-epidermal water loss and skin roughness related to atopic eczema and skin dryness in a population of primary school children. Acta Derm Venereol 2000; 80: 188-191.
9. Rippke F, Schreiner V, Doering T, et al., Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus aureus. Am J Clin Dermatol 2004; 5: 217-223. (Pubitemid 39127965)
10. Mauro T, Holleran WM, Grayson S, et al., Barrier recovery is impeded at neutral pH, independent of ionic effects: implications for extracellular lipid processing. Arch Dermatol Res 1998; 290: 215-222. (Pubitemid 28230774)
11. Bieber T,. Atopic dermatitis. N Engl J Med 2008; 358: 1483-1494.
12. Wehner J, Neuber K,. Staphylococcus aureus enterotoxins induce histamine and leukotriene release in patients with atopic eczema. Br J Dermatol 2001; 145: 302-305. (Pubitemid 32955360)
13. Noble WC,. Carriage of Staphylococcus aureus and beta haemolytic streptococci in relation to race. Acta Derm Venereol 1974; 54: 403-405.
14. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al., Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006; 193: 172-179. (Pubitemid 43113478)
15. Jurevic RJ, Chrisman P, Mancl L, et al., Single-nucleotide polymorphisms and haplotype analysis in beta-defensin genes in different ethnic populations. Genet Test 2002; 6: 261-269. (Pubitemid 36020049)
16. Grundbacher FJ,. Causes of variation in serum IgE levels in normal populations. J Allergy Clin Immunol 1975; 56: 104-111.
17. Sueki H, Whitaker-Menezes D, Kligman AM,. Structural diversity of mast cell granules in black and white skin. Br J Dermatol 2001; 144: 85-93. (Pubitemid 32154597)
18. Barnes KC, Grant AV, Hansel NN, et al., African Americans with asthma: genetic insights. Proc Am Thorac Soc 2007; 4: 58-68. (Pubitemid 46067564)
19. Tey HL, Yosipovitch G,. Itch in ethnic populations. Acta Derm Venereol 2010; 90: 227-234.
20. Steinhoff M, Neisius U, Ikoma A, et al., Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003; 23: 6176-6180. (Pubitemid 36875617)
21. Wang H, Papoiu AD, Coghill RC, et al., Ethnic differences in pain, itch and thermal detection in response to topical capsaicin: African Americans display a notably limited hyperalgesia and neurogenic inflammation. Br J Dermatol 2010; 162: 1023-1029.
22. Alenmyr L, Hogestatt ED, Zygmunt PM, et al., TRPV1-mediated itch in seasonal allergic rhinitis. Allergy 2009; 64: 807-810.
23. Nnoruka EN,. Current epidemiology of atopic dermatitis in south-eastern Nigeria. Int J Dermatol 2004; 43: 739-744. (Pubitemid 39405858)
24. McLaurin CI,. Pediatric dermatology in black patients. Dermatol Clin 1988; 6: 457-473.
25. Summey BT, Bowen SE, Allen HB,. Lichen planus-like atopic dermatitis: expanding the differential diagnosis of spongiotic dermatitis. J Cutan Pathol 2008; 35: 311-314. (Pubitemid 351171252)
26. Pugliarello S, Cozzi A, Gisondi P, et al., Phenotypes of atopic dermatitis. J Dtsch Dermatol Ges 2011; 9: 12-20.
27. Tanaka M, Aiba S, Matsumura N, et al., Prurigo nodularis consists of two distinct forms: early-onset atopic and late-onset non-atopic. Dermatology 1995; 190: 269-276.
28. Berardesca E, Maibach H,. Ethnic skin: overview of structure and function. J Am Acad Dermatol 2003; 48: S139-S142. (Pubitemid 36706254)
29. Ben-Gashir MA, Hay RJ,. Reliance on erythema scores may mask severe atopic dermatitis in black children compared with their white counterparts. Br J Dermatol 2002; 147: 920-925. (Pubitemid 35365438)
30. Ruiz-Maldonado R, Orozco-Covarrubias ML,. Postinflammatory hypopigmentation and hyperpigmentation. Semin Cutan Med Surg 1997; 16: 36-43. (Pubitemid 27214642)
31. Ortonne J,. Vitiligo and Other disorders of Hypopigmentation. In:, Bolognia J, Jorizzo J, Rapini R, eds. Dermatology, 2nd ed. Spain: Elsevier, 2008: 913-938.
32. Hanifin J, Rajka G,. Diagnostic features of atopic dermatitis. Acta Derm Venereol 1980; 92 (Suppl): 44-47.
33. Williams HC, Pembroke AC, Forsdyke H, et al., London-born black Caribbean children are at increased risk of atopic dermatitis. J Am Acad Dermatol 1995; 32: 212-217.
34. Rencic A, Cohen BA,. Prominent pruritic periumbilical papules: a diagnostic sign in pediatric atopic dermatitis. Pediatr Dermatol 1999; 16: 436-438. (Pubitemid 30030324)
35. Uehara M, Hayashi S,. Hyperlinear palms: association with ichthyosis and atopic dermatitis. Arch Dermatol 1981; 117: 490-491. (Pubitemid 11094568)
36. Wells RS,. Some genetic aspects of dermatology: a review. Clin Exp Dermatol 1980; 5: 1-11. (Pubitemid 10130034)
37. Williams HC, Pembroke AC,. Infraorbital crease, ethnic group, and atopic dermatitis. Arch Dermatol 1996; 132: 51-54. (Pubitemid 26024810)
38. Taylor SC,. Skin of color: biology, structure, function, and implications for dermatologic disease. J Am Acad Dermatol 2002; 46: S41-S62. (Pubitemid 41127932)
39. Berardesca E, Maibach HI,. Racial differences in pharmacodynamic response to nicotinates in vivo in human skin: black and white. Acta Derm Venereol 1990; 70: 63-66. (Pubitemid 20088394)
40. Wedig JH, Maibach HI,. Percutaneous penetration of dipyrithione in man: effect of skin color (race). J Am Acad Dermatol 1981; 5: 433-438. (Pubitemid 12247087)
41. Stoughton R,. Bioassay methods for measuring percutaneous absorption. In:, Montagna W, Stoughton RB, vanScott EJ, eds. Pharmacology of the Skin. New York: Appleton-Century-Crofts, 1969: 542-544.
42. Hengge UR, Ruzicka T, Schwartz RA, et al., Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol 2006; 54: 1-15.
43. Eichenfield LF, Lucky AW, Langley RG, et al., Use of pimecrolimus cream 1% (Elidel) in the treatment of atopic dermatitis in infants and children: the effects of ethnic origin and baseline disease severity on treatment outcome. Int J Dermatol 2005; 44: 70-75. (Pubitemid 40201997)
44. Zhou X, Barber WH, Moore CK, et al., Frequency distribution of cytochrome P450 3A4 gene polymorphism in ethnic populations and in transplant recipients. Res Commun Mol Pathol Pharmacol 2006; 119: 89-104. (Pubitemid 47579203)
45. Wandel C, Witte JS, Hall JM, et al., CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism. Clin Pharmacol Ther 2000; 68: 82-91. (Pubitemid 30609830)
46. Kuehl P, Zhang J, Lin Y, et al., Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 2001; 27: 383-391. (Pubitemid 32268418)
47. Dirks NL, Huth B, Yates CR, et al., Pharmacokinetics of immunosuppressants: a perspective on ethnic differences. Int J Clin Pharmacol Ther 2004; 42: 701-718. (Pubitemid 39625130)
48. Meggitt SJ, Gray JC, Reynolds NJ,. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 2006; 367: 839-846. (Pubitemid 43363371)
49. Escousse A, Rifle G, Sgro C, et al., Azathioprine toxicity, 6-mercaptopurine accumulation and the "poor" 6-thiopurine methylator phenotype. Eur J Clin Pharmacol 1995; 48: 309-310.
50. McLeod HL, Lin JS, Scott EP, et al., Thiopurine methyltransferase activity in American white subjects and black subjects. Clin Pharmacol Ther 1994; 55: 15-20. (Pubitemid 24062187)
51. Ranganathan P, Culverhouse R, Marsh S, et al., Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. J Rheumatol 2008; 35: 572-579. (Pubitemid 351500051)
52. Serpa JA, Villarreal-Williams E, Giordano TP,. Prevalence of G6PD deficiency in a large cohort of HIV-infected patients. J Infect 2010; 61: 399-402.
53. Krutmann J, Czech W, Diepgen T, et al., High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992; 26: 225-230.
54. Scheinfeld NS, Tutrone WD, Weinberg JM, et al., Phototherapy of atopic dermatitis. Clin Dermatol 2003; 21: 241-248. (Pubitemid 36629335)
55. Ravnbak MH, Wulf HC,. Pigmentation after single and multiple UV-exposures depending on UV-spectrum. Arch Dermatol Res 2007; 299: 25-32. (Pubitemid 46723570)
56. Jacobe HT, Cayce R, Nguyen J,. UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V. Br J Dermatol 2008; 159: 691-696.